SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-002189
Filing Date
2024-02-29
Accepted
2024-02-29 16:15:33
Documents
15
Period of Report
2024-02-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20240229x8k.htm   iXBRL 8-K 44720
2 EX-99.1 tmb-20240229xex99d1.htm EX-99.1 210867
  Complete submission text file 0001558370-24-002189.txt   391301

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20240229.xsd EX-101.SCH 3124
4 EX-101.LAB tmb-20240229_lab.xml EX-101.LAB 15266
5 EX-101.PRE tmb-20240229_pre.xml EX-101.PRE 9657
16 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240229x8k_htm.xml XML 4675
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 24703843
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)